Viome Life Sciences, a biotech company that analyzes the human microbiome, wants to bring its at-home, RNA-based diagnostic tests to more retail shelves.
Driving the news: To fuel this expansion, Bellevue, Wash.-based Viome closed an $86.5 million Series C.
